Vistagen Therapeutics, Inc.
Biopharma firm developing intranasal therapies for anxiety, depression & neurological disorders.
VTGN | US
Overview
Corporate Details
- ISIN(s):
- US92840H2022
- LEI:
- Country:
- United States of America
- Address:
- 343 ALLERTON AVENUE, 94080 SOUTH SAN FRANCISCO
- Website:
- https://www.vistagen.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Vistagen Therapeutics, Inc. is a late clinical-stage biopharmaceutical company dedicated to developing and commercializing a new class of intranasal therapies for psychiatric and neurological disorders. The company leverages pioneering neuroscience and a deep understanding of nose-to-brain neurocircuitry to advance its pipeline of product candidates, known as "pherines." Vistagen's primary focus is on establishing new standards of care for conditions with large unmet needs, including anxiety and depression disorders. Its mission is to develop innovative, neurocircuitry-focused treatments to provide better outcomes for patients worldwide.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Vistagen Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Vistagen Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Vistagen Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
